Back to search

Belgium· BE-AMP-SAM287515-00

Bonviva 3 mg/3 ml

A ibandronic acid product containing sodium ibandronate monohydrate, registered in Belgium by Atnahs Pharma Netherlands. The same ATC class is registered in 16 of our 19 countries.

ATC M05BA06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedBonviva 3 mg/3 mlATCM05BA06REGISTER NO.BE-AMP-SAM287515-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Ibandronic acid is registered in 16 of 19 countries.

Countries holding a registration under ATC M05BA06 (ibandronic acid), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose

Ibandronic acid · ATC M05BA06

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ibandronic acid costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.089 in United States to $1.30 in Switzerland — a ×15 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Ibandronic acid · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.30
  • ES Spain$0.49
  • IT Italy$0.38
  • US United States$0.089 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Sodium Ibandronate Monohydrate
Manufacturer
Atnahs Pharma Netherlands
Country
Belgium (BE)
ATC code
M05BA06
ATC class
Ibandronic acid
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    2321685
    EUR 32.05
  • be_apb
    0785501

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

228 interactions on record for ibandronic acid.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ibandronic acid · interactions on record

228 records

  • 12 severe
  • 98 moderate
  • 94 info

Most severe, free to view

  • EtelcalcetideH05BX04severe
  • SirolimusL01EG04severe
  • SirolimusL04AA10severe
  • TacrolimusL04AD02severe

24 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ibandronic acid in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ibandronic acid products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Ibandronsäure +pharma, Ibandronsäure Actavis
  • Czechia · Ibandronic Acid Viatris
  • Germany · Ascendra, Ibandronsäure Al
  • Finland · Ibandronate Ratiopharm
  • United Kingdom (Northern Ireland) · Ibandronic Acid Noridem Enterprises
  • Greece · Ibondem
  • Croatia · Ostea
  • Hungary · Bonessa, Etanorden
  • Ireland · Ibandronic Acid Noridem Enterprises
  • Iceland · Ibandronic Acid Wh
  • Italy · Acido Ibandronico Mylan
  • Latvia · Ossica
  • Netherlands · Ibandroninezuur Synthon
  • Poland · Ibandronic Acid Noridem, Osagrand
  • Portugal · Ácido Ibandrónico Gedeon Richter
  • Romania · Ossica
  • Sweden · Ibandronate Bluefish
  • Slovakia · Ossica

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bb5076c3-2c70-4251-a3c7-12f43ba92aa2
GET /v1/drugs/bb5076c3-2c70-4251-a3c7-12f43ba92aa2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Bonviva 3 mg/3 ml",
  "name_fr": "Bonviva 3 mg/3 ml",
  "name_nl": "Bonviva 3 mg/3 ml",
  "amp_code": "SAM287515-00",
  "strengths": [
    "1.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Sodium Ibandronate Monohydrate",
    "Ibandronic Acid",
    "Sodium Acetate Trihydrate",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ibandronic Acid",
  "authorisation_numbers": [
    "EU/1/03/265/005",
    "EU/1/03/265/006"
  ]
}

See everything about ibandronic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.